SPECTRUM PHARMACEUTICALS INC Finite-Lived Intangible Asset, Expected Amortization, Year Five
SPECTRUM PHARMACEUTICALS INC had Finite-Lived Intangible Asset, Expected Amortization, Year Five of $2.47 million as of 2018-12-31, per its 10-K filed 2019-02-28.
Discontinued › Notes › Intangible Assets › Goodwill and Other › Intangible Asset, Finite-Lived, and Capitalized Cost, Software to be Sold, Leased, or Marketed, Estimated Amortization Expense › Intangible Asset, Finite-Lived, after Accumulated Amortization, Estimated Amortization Expense, Fiscal Year Maturity
us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive · last filed 2019-02-28
- 2018-12-31: Finite-Lived Intangible Asset, Expected Amortization, Year Five $2.47M.
- 2018-09-30: Finite-Lived Intangible Asset, Expected Amortization, Year Five $2.47M.
- 2018-06-30: Finite-Lived Intangible Asset, Expected Amortization, Year Five $2.47M.
- 2018-03-31: Finite-Lived Intangible Asset, Expected Amortization, Year Five $2.47M.
| Period end | Finite-Lived Intangible Asset, Expected Amortization, Year Five |
|---|---|
| 2018-12-31 | $2.47M 10-K · filed 2019-02-28 |
| 2018-09-30 | $2.47M 10-Q · filed 2018-11-08 |
| 2018-06-30 | $2.47M 10-Q · filed 2018-08-09 |
| 2018-03-31 | $2.47M 10-Q · filed 2018-05-04 |
| 2017-12-31 | $15.88M 10-K · filed 2018-03-07 |
| 2017-09-30 | $15.88M 10-Q · filed 2017-11-03 |
| 2017-06-30 | $15.88M 10-Q · filed 2017-08-04 |
| 2017-03-31 | $15.88M 10-Q · filed 2017-05-04 |
| 2016-12-31 | $18.27M 10-K · filed 2017-03-14 |
| 2016-09-30 | $18.27M 10-Q · filed 2016-11-14 |
| 2016-06-30 | $18.27M 10-Q · filed 2016-08-09 |
| 2016-03-31 | $14.63M 10-Q · filed 2016-05-06 |
| 2015-12-31 | $15.51M 10-K · filed 2016-03-14 |
| 2015-09-30 | $15.73M 10-Q · filed 2015-11-06 |
| 2015-06-30 | $15.73M 10-Q · filed 2015-08-07 |
| 2015-03-31 | $15.71M 10-Q · filed 2015-05-08 |
| 2014-12-31 | $23.33M 10-K · filed 2015-03-13 |
| 2014-09-30 | $22.62M 10-Q · filed 2014-11-10 |
| 2014-06-30 | $19.16M 10-Q · filed 2014-08-08 |
| 2014-03-31 | $19.18M 10-Q · filed 2014-05-12 |
| 2013-12-31 | $22.31M 10-K · filed 2014-03-12 |